4C7J

11b-Hydroxysteroid Dehydrogenase Type I in complex with inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.16 Å
  • R-Value Free: 0.240 
  • R-Value Work: 0.174 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

Optimization of Brain Penetrant 11Beta-Hydroxysteroid Dehydrogenase Type I Inhibitors and in Vivo Testing in Diet- Induced Obese Mice.

Goldberg, F.W.Dossetter, A.G.Scott, J.S.Robb, G.R.Boyd, S.Groombridge, S.D.Kemmitt, P.D.Sjogren, T.Gutierrez, P.M.Deschoolmeester, J.Swales, J.G.Turnbull, A.V.Wild, M.J.

(2014) J.Med.Chem. 57: 970

  • DOI: 10.1021/jm4016729
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) has been widely considered by the pharmaceutical industry as a target to treat metabolic syndrome in type II diabetics. We hypothesized that central nervous system (CNS) penetration might be required ...

    11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) has been widely considered by the pharmaceutical industry as a target to treat metabolic syndrome in type II diabetics. We hypothesized that central nervous system (CNS) penetration might be required to see efficacy. Starting from a previously reported pyrimidine compound, we removed hydrogen-bond donors to yield 3, which had modest CNS penetration. More significant progress was achieved by changing the core to give 40, which combines good potency and CNS penetration. Compound 40 was dosed to diet-induced obese (DIO) mice and gave excellent target engagement in the liver and high free exposures of drug, both peripherally and in the CNS. However, no body weight reduction or effects on glucose or insulin were observed in this model. Similar data were obtained with a structurally diverse thiazole compound 51. This work casts doubt on the hypothesis that localized tissue modulation of 11β-HSD1 activity alleviates metabolic syndrome.


    Organizational Affiliation

    AstraZeneca , Mereside, Alderley Park, Macclesfield SK10 4TG, United Kingdom.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
CORTICOSTEROID 11-BETA-DEHYDROGENASE ISOZYME 1
A, B, C, D
269Homo sapiensMutation(s): 4 
Gene Names: HSD11B1 (HSD11, HSD11L, SDR26C1)
EC: 1.1.1.146
Find proteins for P28845 (Homo sapiens)
Go to Gene View: HSD11B1
Go to UniProtKB:  P28845
Small Molecules
Ligands 2 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
NAP
Query on NAP

Download SDF File 
Download CCD File 
A, B, C, D
NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE
2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE
C21 H28 N7 O17 P3
XJLXINKUBYWONI-NNYOXOHSSA-N
 Ligand Interaction
4YQ
Query on 4YQ

Download SDF File 
Download CCD File 
A, B, C, D
4-cyclopropyl-2-(2-hydroxyethyloxy)-N-[(1S,3R)-5-oxidanyl-2-adamantyl]-1,3-thiazole-5-carboxamide
C19 H26 N2 O4 S
NJXRHIKVLFLBME-WCUHCKLXSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
4YQIC50: 9.9 nM BINDINGMOAD
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.16 Å
  • R-Value Free: 0.240 
  • R-Value Work: 0.174 
  • Space Group: P 21 21 21
Unit Cell:
Length (Å)Angle (°)
a = 95.686α = 90.00
b = 98.435β = 90.00
c = 99.112γ = 90.00
Software Package:
Software NamePurpose
XDSdata scaling
MOSFLMdata reduction
REFMACrefinement
MOLREPphasing

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2014-09-03
    Type: Initial release
  • Version 1.1: 2018-04-04
    Type: Data collection